C-6 aryl substituted 4-quinolone-3-carboxylic acids as inhibitors of hepatitis C virus. 2012

Yue-Lei Chen, and Jeana Zacharias, and Robert Vince, and Robert J Geraghty, and Zhengqiang Wang
Center for Drug Design, Academic Health Center, University of Minnesota, Minneapolis, MN 55455, USA.

Quinolone-3-carboxylic acid represents a highly privileged chemotype in medicinal chemistry and has been extensively explored as antibiotics and antivirals targeting human immunodeficiency virus (HIV) integrase (IN). Herein we describe the synthesis and anti-hepatitis C virus (HCV) profile of a series of C-6 aryl substituted 4-quinlone-3-carboxylic acid analogues. Significant inhibition was observed with a few analogues at low micromolar range against HCV replicon in cell culture and a reduction in replicon RNA was confirmed through an RT-qPCR assay. Interestingly, evaluation of analogues as inhibitors of NS5B in a biochemical assay yielded only modest inhibitory activities, suggesting that a different mechanism of action could operate in cell culture.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D012093 Replicon Any DNA sequence capable of independent replication or a molecule that possesses a REPLICATION ORIGIN and which is therefore potentially capable of being replicated in a suitable cell. (Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Replication Unit,Replication Units,Replicons,Unit, Replication,Units, Replication
D002264 Carboxylic Acids Organic compounds containing the carboxy group (-COOH). This group of compounds includes amino acids and fatty acids. Carboxylic acids can be saturated, unsaturated, or aromatic. Carboxylic Acid,Acid, Carboxylic,Acids, Carboxylic
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Yue-Lei Chen, and Jeana Zacharias, and Robert Vince, and Robert J Geraghty, and Zhengqiang Wang
January 1974, Journal of medicinal chemistry,
Yue-Lei Chen, and Jeana Zacharias, and Robert Vince, and Robert J Geraghty, and Zhengqiang Wang
July 2014, Bioorganic & medicinal chemistry,
Yue-Lei Chen, and Jeana Zacharias, and Robert Vince, and Robert J Geraghty, and Zhengqiang Wang
September 1986, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Yue-Lei Chen, and Jeana Zacharias, and Robert Vince, and Robert J Geraghty, and Zhengqiang Wang
January 2005, Bioorganic & medicinal chemistry,
Yue-Lei Chen, and Jeana Zacharias, and Robert Vince, and Robert J Geraghty, and Zhengqiang Wang
May 2018, Bioorganic & medicinal chemistry,
Yue-Lei Chen, and Jeana Zacharias, and Robert Vince, and Robert J Geraghty, and Zhengqiang Wang
October 2008, Bioorganic & medicinal chemistry,
Yue-Lei Chen, and Jeana Zacharias, and Robert Vince, and Robert J Geraghty, and Zhengqiang Wang
August 2014, Bioorganic & medicinal chemistry letters,
Yue-Lei Chen, and Jeana Zacharias, and Robert Vince, and Robert J Geraghty, and Zhengqiang Wang
September 1986, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Yue-Lei Chen, and Jeana Zacharias, and Robert Vince, and Robert J Geraghty, and Zhengqiang Wang
July 1999, The Journal of organic chemistry,
Copied contents to your clipboard!